Evidence map›Paper›PMID 34998257›Full record

ArticleDrug and alcohol dependence2022

HIV, psychological resilience, and substance misuse during the COVID-19 pandemic: A multi-cohort study.

Marianna K Baum, Javier A Tamargo, Janet Diaz-Martinez, Ivan Delgado-Enciso, Christina S Meade, Gregory D Kirk, Shruti H Mehta, Richard Moore, Michele D Kipke, Steven J Shoptaw and 6 more

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Low Psychological Resilience Predict the Risk for Alcohol Use Disorder in General Population: National Mental Health Survey of Korea 2021.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Childhood trauma, substance use and depressive symptoms in people with HIV during COVID-19.The South African journal of psychiatry : SAJP : the journal of the Society of Psychiatrists of South Africa · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 10 institutions in 1 country.

Marianna K BaumRobert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA. Electronic address: baumm@fiu.edu.
Javier A TamargoRobert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA.
Janet Diaz-MartinezRobert Stempel College of Public Health and Social Work, Florida International University, Miami, FL, USA.
Ivan Delgado-EncisoSchool of Medicine, University of Colima, Colima, MX, USA.
Christina S MeadeDuke University School of Medicine, Duke University, Durham, NC, USA.
Gregory D KirkBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Shruti H MehtaBloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Richard MooreJohns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Michele D KipkeKeck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Steven J ShoptawDavid Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Brian MustanskiFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Raul N MandlerNational Institute on Drug Abuse, Rockville, MD, USA.
Jag H KhalsaGeorge Washington University, Washington, DC, USA.
Suzanne SiminskiFrontier Science Foundation, Brookline, MA, USA.
Marjan JavanbakhtFielding School of Public Health, University of California, Los Angeles, CA, USA.
Pamina M GorbachFielding School of Public Health, University of California, Los Angeles, CA, USA.
Florida International University · USUniversity of California, Los Angeles · USJohns Hopkins University · USDuke University · USFrontier Science & Technology Research Foundation · USGeorge Washington University · USJohns Hopkins Medicine · USNational Institute on Drug Abuse · USNorthwestern University · USUniversity of Southern California · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
The RADAR cohort study of multilevel Influences on HIV and substance useU01DA036939 · NIDA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Brian Mustanski, Michael E Newcomb · 2014 to 2026
$29.5M
The AIDS Linked to the Intravenous Experience (ALIVE) StudyU01DA036297 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Gregory D Kirk, Shruti H Mehta · 2014 to 2026
$28.9M
Young Men of Color Who Have Sex with Men Cohort StudyU01DA036926 · NIDA · CHILDREN'S HOSPITAL OF LOS ANGELES · PI GOLDBACH, JEREMY THOMAS, KIPKE, MICHELE D. · 2015 to 2024
$23.3M
MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE) U01DA036267 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SHOPTAW, STEVEN J · 2013 to 2024
$20.5M
Johns Hopkins HIV Clinical CohortU01DA036935 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MOORE, RICHARD DOUGLAS · 2014 to 2024
$14.9M
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular DiseaseU01DA040325 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LAI, SHENGHAN · 2016 to 2024
$12.7M
Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDSU01DA038886 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI DEBECK, KORA, HAYASHI, KANNA · 2015 to 2024
$12.1M
Community-Engaged Research on COVID-19 Testing Among Underserved and/or Vulnerable PopulationsU01DA040381 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI BAUM, MARIANNA K · 2015 to 2022
$9.6M
Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) Second Bridge Funding SupplementU24DA044554 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GORBACH, PAMINA MAE, SIMINSKI, SUZANNE M. · 2017 to 2022
$6.8M
Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersU01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2017 to 2024
$4.3M
NIAID NIH HHS P30 AI064518NIDA NIH HHS U01 DA021525NIDA NIH HHS U01 DA036267NIDA NIH HHS U01 DA036297NIDA NIH HHS U01 DA036926NIDA NIH HHS U01 DA036935NIDA NIH HHS U01 DA036939NIDA NIH HHS U01 DA038886NIDA NIH HHS U01 DA040325NIDA NIH HHS U01 DA040381NIDA NIH HHS U24 DA044554NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

objectiveThe COVID-19 pandemic has dramatically impacted mental health, increasing rates of substance misuse. Resilience is a positive adaptation to stress that may act as a buffer against adverse mental health outcomes. Based on prior knowledge, we hypothesized that PLWH would display higher resilience than HIV-uninfected peers, and that high resilience would be associated with lower risk of substance misuse.

methodsThis analysis of the Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) included data from six USA cohorts that administered a COVID-19-related survey with a 3-month follow-up during May 2020 and March 2021. All data was self-reported. The Brief Resilience Scale and General Anxiety Disorder-7 were utilized. Primary analyses consisted of multivariate generalized linear mixed models with random intercepts using binary logistic regression.

resultsA total of 1430 participants completed both surveys, of whom 670 (46.9%) were PLWH. PLWH had lower odds of anxiety (OR=0.67, 95% CI: 0.51-0.89) and higher odds of high resilience (OR=1.21, 95% CI: 1.02-1.44) than HIV-uninfected participants, adjusted for covariates. The presence of anxiety was associated with higher risk of misuse of all substances. High resilience was associated with lower risk of anxiety and misuse of substances, adjusted for covariates.

conclusionsPsychological resilience was associated with lower risk of anxiety and substance misuse, potentially serving as a buffer against poor mental and behavioral health during the COVID-19 pandemic. Further research is needed to identify pathways of resilience in the context of substance misuse and comprehensive resilience-focused interventions.

Indexed as

COVID-19HIV InfectionsResilience, PsychologicalSubstance-Related DisordersAnxietyCohort StudiesDepressionHumansPandemicsSARS-CoV-2COVID-19HIVMental healthPsychological adaptationSubstance Use

Identifiers

PMID34998257
PMCPMC8704725
OpenAlexW4200587844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.